glp-1 news today 2025 october 9 FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Agonists: Using Semaglutide, Tirzepatide,

The decision to continue, adjust, or discontinue semaglutide should be based on the overall risk-benefit assessment and whether a plausible connection between the medication and back pain can be established through clinical evaluation

Many patients experience improvements in insulin sensitivity, reversal of prediabetes, and overall metabolic flexibility

The short answer: GLP-1 medications don't directly increase or replace estrogen, progesterone, or other reproductive hormones

This is an expected outcome of the peptide's primary mechanism

This integrated formulation is designed with scientifically-backed natural ingredients to help individuals lose weight incrementally by supporting their L-Cells where the body produces GLP-1

How long does a child stay on sermorelin